Reuters logo
Dr. Reddy's Q4 profit up 25 pct, lags estimates
May 13, 2014 / 8:31 AM / 3 years ago

Dr. Reddy's Q4 profit up 25 pct, lags estimates

MUMBAI, May 13 (Reuters) - Dr. Reddy’s Laboratories Ltd , India’s second-largest drugmaker by sales, on Tuesday posted a 25 percent rise in quarterly net profit, but fell short of analysts’ estimates due to a rise in expenses.

Net profit for the January-March quarter was 4.71 billion rupees ($78.68 million), compared with 3.78 billion rupees in the same period a year ago. Analysts on average expected a profit of 6.1 billion rupees, according to Thomson Reuters data.

Dr. Reddy‘s, a leading player in India’s $14 billion generic drugs industry, posted revenue of 25.32 billion rupees, up 17 percent from the prior year.

Shares in the Hyderabad-based company, valued at nearly $8 billion, fell 3 percent to 2,650 rupees on Tuesday after the earnings, while the main Mumbai market was up 2 percent.($1 = 59.8650 Indian Rupees) (Reporting by Zeba Siddiqui in Mumbai; Editing by Matt Driskill)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below